Cannabis and cannabinoids for the treatment of acute and chronic pain

被引：4
|
作者：
Schafer, Michael [1 ]
Tafelski, Sascha [1 ]
机构：
[1] Charite Univ Med Berlin, Klin Anasthesiol & Intensivmed, Berlin, Germany
来源：
ANAESTHESIST | 2021年 / 70卷 / 07期
关键词：
Tetrahydrocannabinol; Cannabidiol; Acute pain; Chronic pain; Cannabinoid receptors; DOUBLE-BLIND; CONTROLLED-TRIAL; CANCER-PATIENTS; ORAL DELTA-9-TETRAHYDROCANNABINOL; POSTOPERATIVE NAUSEA; NEUROPATHIC PAIN; OROMUCOSAL SPRAY; OPEN-LABEL; EFFICACY; PLACEBO;
D O I：
10.1007/s00101-021-00994-9
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Since the Act on the medical use of cannabis, at which cannabis-based medicines and cannabinoids became law, there has been an exponential increase in prescriptions for the acquisition of cannabis for medical purposes. The aim of this leading article is to compile and assess the currently available relevant clinical evidence for the use of cannabis and cannabinoids for treatment of acute and chronic pain. Based on the systematic literature review "Cannabis-Potential and risks (CAPRIS)" commissioned by the German Federal Ministry of Health and the recently published recommendations of the European Pain Federation EFIC, this article aims to give an orientation aid for the decision-making process in the clinical routine.
引用
收藏
页码：551 / 562
页数：12
相关论文
共 50 条
  • [11] Medical cannabis and cannabinoids for chronic pain: Summary of a Rapid Recommendation
    Busse, Jason W.
    MacKillop, James
    JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH, 2021, 7 : 118 - 122
  • [12] Cannabinoids and Their Role in Chronic Pain Treatment: Current Concepts and a Comprehensive Review
    Shehata, Islam
    Hashim, Ahmed
    Elsaeidy, Ahmed
    Nair, Anagha
    Urits, Ivan
    Viswanath, Omar
    Kaye, Alan
    Habib, Marian
    HEALTH PSYCHOLOGY RESEARCH, 2022, 10 (04):
  • [13] Medicinal cannabis products for the treatment of acute pain
    Fiore, Marco
    Alfieri, Aniello
    Di Franco, Sveva
    Petrou, Stephen
    Damiani, Giovanni
    Pace, Maria Caterina
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (12)
  • [14] Efficiency of cannabis and cannabidiol in managing chronic pain syndromes: A comprehensive narrative review
    Bort, Marta
    Olchowy, Cyprian
    Olchowy, Anna
    Nawrot-Hadzik, Izabela
    Smardz, Joanna
    Wieckiewicz, Mieszko
    DENTAL AND MEDICAL PROBLEMS, 2024, 61 (05) : 765 - 782
  • [15] Topical Lidocaine for Chronic Pain Treatment
    Voute, Marion
    Morel, Veronique
    Pickering, Gisele
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 4091 - 4103
  • [16] Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
    Darkovska-Serafimovska, Marija
    Serafimovska, Tijana
    Arsova-Sarafinovska, Zorica
    Stefanoski, Sasho
    Keskovski, Zlatko
    Balkanov, Trajan
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 837 - 842
  • [17] Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials
    Fisher, Emma
    Moore, R. Andrew
    Fogarty, Alexandra E.
    Finn, David P.
    Finnerup, Nanna B.
    Gilron, Ian
    Haroutounian, Simon
    Krane, Elliot
    Rice, Andrew S. C.
    Rowbotham, Michael
    Wallace, Mark
    Eccleston, Christopher
    PAIN, 2021, 162 : S45 - S66
  • [18] Cannabinoids for the treatment of chronic neuropathic pain and spasticity
    Karst M.
    MMW - Fortschritte der Medizin, 2022, 164 (Suppl 1) : 51 - 60
  • [19] The Current Role of Cannabinoids in the Treatment of Chronic Pain
    Przeklasa-Muszynska, A.
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2018, 20 : 23 - 23
  • [20] Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
    Lynch, Mary E.
    Campbell, Fiona
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (05) : 735 - 744
12345